Parallel Advisors’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09K | Buy |
958
+812
| +556% | +$4.31K | ﹤0.01% | 2714 |
|
|
2025
Q1 | $1.3K | Buy |
146
+24
| +20% | +$213 | ﹤0.01% | 3054 |
|
|
2024
Q4 | $1.67K | Sell |
122
-651
| -84% | -$8.93K | ﹤0.01% | 2991 |
|
|
2024
Q3 | $21.2K | Hold |
773
| – | – | ﹤0.01% | 2053 |
|
|
2024
Q2 | $18.9K | Sell |
773
-3
| -0.4% | -$73 | ﹤0.01% | 2013 |
|
|
2024
Q1 | $16.5K | Sell |
776
-33
| -4% | -$704 | ﹤0.01% | 2079 |
|
|
2023
Q4 | $15.5K | Buy |
809
+708
| +701% | +$13.6K | ﹤0.01% | 2096 |
|
|
2023
Q3 | $1.62K | Hold |
101
| – | – | ﹤0.01% | 2877 |
|
|
2023
Q2 | $2.34K | Sell |
101
-10
| -9% | -$232 | ﹤0.01% | 2707 |
|
|
2023
Q1 | $2.58K | Sell |
111
-12
| -10% | -$279 | ﹤0.01% | 2668 |
|
|
2022
Q4 | $1.79K | Buy |
123
+3
| +3% | +$44 | ﹤0.01% | 2725 |
|
|
2022
Q3 | $2K | Buy |
120
+19
| +19% | +$317 | ﹤0.01% | 2678 |
|
|
2022
Q2 | $2K | Buy |
101
+10
| +11% | +$198 | ﹤0.01% | 2584 |
|
|
2022
Q1 | $2K | Hold |
91
| – | – | ﹤0.01% | 2585 |
|
|
2021
Q4 | $3K | Hold |
91
| – | – | ﹤0.01% | 2585 |
|
|
2021
Q3 | $3K | Buy |
91
+19
| +26% | +$626 | ﹤0.01% | 2555 |
|
|
2021
Q2 | $2K | Hold |
72
| – | – | ﹤0.01% | 2561 |
|
|
2021
Q1 | $2K | Buy |
+72
| New | +$2K | ﹤0.01% | 2472 |
|
|
2018
Q4 | – | Sell |
-14
| Closed | -$1K | – | 2228 |
|
|
2018
Q3 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 2141 |
|